An interview with Sriram Krishnan, who says "there will not be an FDA for AI" under Trump, blames the AI backlash on the industry's "doomer" messaging, and more (Financial Times)

Summary

Financial Times: An interview with Sriram Krishnan, who says “there will not be an FDA for AI” under Trump, blames the AI backlash on the industry's “doomer” messaging, and more — Sriram Krishnan tells the FT the president is against a centralised regulator as AI backlash grows

SpinGraph analysis pending — check back after processing.

• Meta could use its compute for its own models, ad scaling, SpaceX-like neocloud deals, and hosting 3rd-party models; it may be close to an Anthropic deal (Jeremie Eliahou Ontiveros/SemiAnalysis)
• Meta getting into the cloud business has been inevitable for a long time, as it seeks to diversify beyond ad revenue and monetize its AI buildout (M.G. Siegler/Spyglass)
• Instagram has been running ads promoting child sexual abuse material in India, with terms like "rape video" and "child video" and linking to Telegram channels (Divya Arya/BBC)
• Texas AG Ken Paxton opens an investigation into StubHub following complaints of last-minute ticket cancellations for FIFA World Cup matches (Giles Turner/Bloomberg)
• How Jeff Bezos' changing relationship with President Trump has impacted his companies, including increased federal contract awards during Trump's second term (Wall Street Journal)
• Pitch document: Chris Larsen and Palmer Luckey invested an undisclosed amount in APEC, a derivatives exchange founded by the son of Senator Kirsten Gillibrand (Declan Harty/Politico)